71
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

Postprandial Glycaemic Effect of a Peptide Fraction of Salvia Hispanica in Patients with Insulin Resistance

, , , & ORCID Icon
Pages 356-362 | Received 30 Jan 2021, Accepted 09 Jun 2021, Published online: 11 Jul 2021
 

Abstract

Diabetes is a prevalent metabolic disorder among almost every single population on the planet. Diet has a fundamental impact on both treatment and control. The consumption of several plant seeds has been associated with improvement in glucose tolerance and absorption. A randomized controlled trial was conducted to evaluate the glycaemic effects of a hydrolyzed peptide fraction of Salvia hispanica seed through postprandial quantification on blood glucose, plasma insulin, and Matsuda-DeFronzo index in patients with insulin resistance or incipient type 2 diabetes. Both Chia and control proteins were mixed with a portion of liquid food and provided to nine participants. A mixed-food tolerance curve was performed. A reduction in glucose concentrations was observed after 30 minutes in subjects consuming Chia seeds' peptides. However, no significant effect on plasmatic insulin was found. The consumption of peptide fractions of Chia seeds could decrease the acute absorption of carbohydrates and attenuate acute postprandial hyperglycemia in patients with T2D. However, these apparent benefits do not appear to modulate insulin sensitivity.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.